News
Lilly's BTK drug Jaypirca joins first-line options in US
Lilly's noncovalent BTK inhibitor Jaypirca has been cleared by the FDA for its first frontline indication, but will it be reserved for later-line use?
News
Shionogi's diversification continues with $2bn IntraBio buy
Shionogi has reached a $2bn agreement to buy Anglo-US biotech IntraBio and its recently approved Aqneursa therapy for two rare genetic disorders.
News
Novo faces delay in US review of haemophilia drug
The FDA has extended its review of Novo's experimental haemophilia A drug denecimig because of ongoing remediation work at a manufacturing facility.
News
Bayer pledges $2.2bn to US manufacturing facility
Bayer has joined the ranks of pharma groups planning major facility investments in the US, with a $2.2bn plan for a new production unit in Ohio.
Sales & Marketing
Your launch strategy has never met the competition
Will your launch strategy work once it has finally left the meeting room and met the competition?
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
